Baseline characteristics of AVF patients with VA dysfunction.

Baseline characteristics of AVF patients with VA dysfunction.</p

Comparison of VA dysfunction risk at <1 year and >1 year after VA creation in AVG patients who received different doses of antiplatelet drugs.

Comparison of VA dysfunction risk at 1 year after VA creation in AVG patients who received different doses of antiplatelet drugs.</p

Comparison of VA dysfunction risk at <1 year and >1 year after VA creation in AVF and AVG patients who used different medications.

Comparison of VA dysfunction risk at 1 year after VA creation in AVF and AVG patients who used different medications.</p

Comparison of VA dysfunction risk at <1 year and >1 year after VA creation in AVF patients who received different doses of antiplatelet drugs.

Comparison of VA dysfunction risk at 1 year after VA creation in AVF patients who received different doses of antiplatelet drugs.</p

Baseline characteristics of AVG patients with VA dysfunction.

Baseline characteristics of AVG patients with VA dysfunction.</p

Flowchart of selection criteria and process of patients receiving hemodialysis and experienced vascular access (VA) dysfunction.

The time of occurrence of VA dysfunction was used to define two subgroups, namely short-term (S) (<1 year) and long-term (L) (≥1 year) VA dysfunction. AVF, arteriovenous fistula; AVG, arteriovenous graft; ESRD, end-stage renal disease.</p

The melt inpregnation of continuous fibre tows in the processing of thermoplastic matrix composites

SIGLEAvailable from British Library Document Supply Centre-DSC:DX189139 / BLDSC - British Library Document Supply CentreGBUnited Kingdo

The trends of sibling recurrence risk ratios λof individual components of the metabolic syndrome and the syndrome per se in Cohort 1 (A) and Cohort 2 (B)

<p><b>Copyright information:</b></p><p>Taken from "Sibling recurrence risk ratio analysis of the metabolic syndrome and its components over time"</p><p>http://www.biomedcentral.com/1471-2156/4/s1/S33</p><p>BMC Genetics 2003;4(Suppl 1):S33-S33.</p><p>Published online 31 Dec 2003</p><p>PMCID:PMC1866469.</p><p></p

Results of a multivariate analysis between risk factors and severe injury.

Results of a multivariate analysis between risk factors and severe injury.</p

Flow chart for sample selection.

Flow chart for sample selection.</p